GERN

Geron Corporation News Headlines

$3.26
*  
0.01
0.31%
Get GERN Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading GERN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
12/19/2014 4:00:00 PM - Seeking Alpha


Geron Enters 2015 On A More Assured Note
12/18/2014 3:28:00 PM - Seeking Alpha


Market Has Not Yet Noticed Potential in Geron (GERN); Have You? - Tale of the Tape
12/17/2014 9:02:00 AM - Zacks.com


4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog
12/16/2014 11:26:00 AM - Investopedia


Why Geron Corporation (GERN) Stock Might be a Great Pick - Tale of the Tape
12/10/2014 8:57:00 AM - Zacks.com


Health Care Sector Update for 12/05/2014: GERN,ATOS,PBMD
12/5/2014 1:23:22 PM - MT Newswires


Geron (GERN) Stock: Moving Average Crossover Alert - Tale of the Tape
12/5/2014 9:47:10 AM - Zacks.com


Geron To Present At Piper Jaffray Conference; Webcast At 4:00 PM ET
12/3/2014 3:01:00 PM - RTT News


BioTime Harnesses Geron's Stem Cell Technology And Its Founder; Is That Enough To Survive The Biotech Revolution?
12/3/2014 10:51:00 AM - Seeking Alpha


Why Geron Corporation Stock Surged 65% in November
12/2/2014 12:30:11 PM - Motley Fool


3 Biotech Stocks With Jaw-Dropping Growth Potential in 2015
11/29/2014 2:01:03 PM - Motley Fool


3 Healthcare Stocks Short-Sellers Are Wrong About
11/21/2014 10:27:02 AM - Motley Fool


Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog
11/19/2014 11:23:00 AM - Zacks.com


Can the Rally in Geron (GERN) Shares Continue? - Tale of the Tape
11/19/2014 8:43:22 AM - Zacks.com


Geron Collaborates with J&J for Imetelstat - Analyst Blog
11/14/2014 6:00:00 PM - Zacks.com


Geron's Short Squeeze Is Here
11/14/2014 3:40:00 PM - Seeking Alpha


Health Care Sector Update for 11/14/2014: GERN,JNJ,IMUC,VASC
11/14/2014 2:06:22 PM - MT Newswires


Geron's Risk/Reward Profile Improves As Near-Term Uncertainty Ends
11/7/2014 1:06:00 PM - Seeking Alpha


Biotech Stock Roundup: Regeneron's Eylea Stumbles, Geron Up on Lifting of Clinical Hold - Analyst Blog
11/5/2014 9:46:00 AM - Zacks.com


Mid-Day Market Update: Ford Falls On October Sales Report; Geron Shares Climb
11/3/2014 1:20:18 PM - Benzinga


Mid-Morning Market Update: Markets Mixed; Publicis To Acquire Sapient For $3.7 Billion
11/3/2014 11:14:12 AM - Benzinga


Why Geron Corporation Shares Skyrocketed
11/3/2014 11:06:01 AM - Motley Fool


Pre-Market Most Active for Nov 3, 2014 : SAPE, ARCP, GERN, SAP, WAC, NOK, UN, FB, BABA, PBR, TVIX, AAPL
11/3/2014 8:39:51 AM - NASDAQ.com News


Betting On Big Data To Beat Aging
10/28/2014 4:31:00 PM - Seeking Alpha


Is Sarepta Therapeutics Inc. Stock a Short Sell?
10/13/2014 8:05:02 AM - Motley Fool